Dronedarone
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 808 publications
Pharmacologic Rhythm Control for Atrial Fibrillation with Dronedarone versus Sotalol in Patients with and without Heart Failure.
Journal: Current problems in cardiology
Published: March 14, 2026
Dronedarone synergizes with colistin against planktonic and biofilm forms of multidrug-resistant Gram-negative pathogens.
Journal: Microbiology spectrum
Published: December 23, 2025
Clinical and Economic Outcomes of Dronedarone Versus Amiodarone Among Patients With Atrial Fibrillation.
Journal: Journal of the American Heart Association
Published: December 18, 2025
Efficacy and Safety of Dronedarone in Overweight and Obesity: Post Hoc Analysis of the ATHENA Trial.
Efficacy and Safety of Dronedarone in Overweight and Obesity: Post Hoc Analysis of the ATHENA Trial.
Journal: Journal of cardiovascular electrophysiology
Published: December 12, 2025
Repurposing dronedarone induces ferroptosis through GPX4 inactivation and degradation in pancreatic cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 02, 2025
New recommendations for rhythm control-What has changed in the 2023 ACC/AHA/ACCP/HRS and 2024 ESC guidelines for atrial fibrillation, and where does dronedarone fit in?
Journal: American heart journal plus : cardiology research and practice
Published: October 10, 2025
Dronedarone hydrochloride targets cardiolipin and phosphatidylglycerol to increase colistin susceptibility in gram-negative pathogens.
Journal: Microbiology spectrum
Published: September 30, 2025
Repurposing dronedarone for colorectal cancer therapeutic via suppression of the AKT/ERK signaling pathways.
Journal: Biochemical pharmacology
Published: September 18, 2025
Identification of cellular ion channels that facilitate Hazara nairovirus infection enables selection of clinically approved compounds with anti-nairoviral properties.
Journal: Scientific reports
Published: September 11, 2025
Factors influencing the inappropriate dosing of rivaroxaban and edoxaban in Chinese hospitalized patients with atrial fibrillation.
Journal: Frontiers in cardiovascular medicine
Published: August 29, 2025
Comment on Impact of amiodarone on plasma concentration of direct oral anticoagulant in patients with atrial fibrillation.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: August 29, 2025
Last Updated: 04/28/2026